source
- Neumora drug fails two more Phase 3 trials, biotech to lay off 35% of staffThe Really Big Neuroscience Company is proving to be a Really Big Flop with each passing update. Neumora Therapeutics will discontinue its lead depression drug after it failed another two Phase 3 s…Endpoints · 1mo ago↗ source
- Medicare drug price rule may target under-the-skin Keytruda and OpdivoFor 2029, a federal rule proposes closing a "loophole" that protects medicines transitioning from intravenous administration from price protection.BioPharma Dive · 1mo ago↗ source
- Six leaders working on LGBTQ+ inclusion in biopharmaIt’s been a tough 18 months for the LGBTQ+ community. The American Civil Liberties Union tracked 530 anti-LGBTQ bills across dozens of states this year. Nearly 40% of US workers say ...